Literature DB >> 16214366

The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1.

Chiara Battelli1, George N Nikopoulos, Jane G Mitchell, Joseph M Verdi.   

Abstract

RNA-binding proteins regulate cell fate decisions during nervous system development. The Msi family of RNA-binding proteins is expressed in multipotential neural progenitors, and is required for maintaining cells in a proliferative state. We demonstrate that Msi-1's ability to regulate progenitor maintenance is through the translational inhibition of the cyclin-dependent kinase inhibitor p21WAF-1. Msi-1 ectopic expression increases the proliferation rate and the capacity to regulate p21WAF-1 protein expression, independent of p53. The 3' untranslated region (UTR) of the native p21(WAF-1) mRNA contains a Msi-1 consensus-binding site that permits Msi-1 to directly repress the translation of p21WAF-1 protein. Reduction of Msi-1 through antisense leads to aberrant p21WAF-1 expression, which significantly impairs neural differentiation. A double knockdown for p21WAF-1 and Msi-1 rescues the production of mature MAP+ neurons. Our results further elucidate the symbiotic relationship between cell cycle withdrawal and the onset of differentiation in the developing nervous system, as well as increasing the understanding of the influence that RNA-binding proteins serve in regulating these processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214366     DOI: 10.1016/j.mcn.2005.09.003

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  100 in total

1.  Autoregulation of Musashi1 mRNA translation during Xenopus oocyte maturation.

Authors:  Karthik Arumugam; Melanie C Macnicol; Angus M Macnicol
Journal:  Mol Reprod Dev       Date:  2012-07-09       Impact factor: 2.609

Review 2.  Context-dependent regulation of Musashi-mediated mRNA translation and cell cycle regulation.

Authors:  Melanie C MacNicol; Chad E Cragle; Angus M MacNicol
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

3.  A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.

Authors:  Nate P Hoverter; Ju-Hui Ting; Suman Sundaresh; Pierre Baldi; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

4.  The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells.

Authors:  Chann Lagadec; Erina Vlashi; Patricia Frohnen; Yazeed Alhiyari; Mabel Chan; Frank Pajonk
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

5.  The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity.

Authors:  Nicole A Siddall; Eileen A McLaughlin; Neisha L Marriner; Gary R Hime
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

6.  RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript.

Authors:  Limin Shu; Wensheng Yan; Xinbin Chen
Journal:  Genes Dev       Date:  2006-10-18       Impact factor: 11.361

Review 7.  Stem Cells, Cancer, and MUSASHI in Blood and Guts.

Authors:  Michael G Kharas; Christopher J Lengner
Journal:  Trends Cancer       Date:  2017-04-08

Review 8.  Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

Authors:  Alexander E Kudinov; John Karanicolas; Erica A Golemis; Yanis Boumber
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

Review 9.  Post-transcriptional regulatory elements and spatiotemporal specification of neocortical stem cells and projection neurons.

Authors:  E M DeBoer; M L Kraushar; R P Hart; M-R Rasin
Journal:  Neuroscience       Date:  2013-05-30       Impact factor: 3.590

Review 10.  Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.

Authors:  Jin Zhang; Xinbin Chen
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.